Category: health
Our mission is to provide health care tips empowering, evidence-based information that you can use to help yourself and your loved ones. Our health blogs help you help yourself by offering guidance and encouragement. By following our blogs you will start feeling better. We aim to provide articles that give the audience better information that can improve their lives. Our blogs cover topics such as health, fitness and their supplements. Also, it focuses on the essential things you need to know to understand the problem you’re facing, make informed decisions, and take positive steps. We deliver our readers a better online experience. Read on!
Sanofi: French drugmaker Sanofi looks to spin off its consumer business in India
French drugmaker Sanofi has initiated a process to turn its consumer healthcare business in India into a listed entity through a demerger, said people with knowledge of the matter. The unit’s products include leading anti-allergy brands such as Allegra and Avil, pain management drug Combiflam and Vitamin D brand Depura. The business posted revenue of ...
food for special medical purposes: Govt exempts import duty on drugs, food for special medical purposes for personal use to treat rare diseases
The government on Thrusday exempted basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment of rare diseases, stated a government press release. The import duty waiver will come into effect from April 1. Also, the government has exempted Pembrolizumab (Keytruda), used in treatment of various cancers, ...
Cipla: Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV’s HIV preventive therapy
ViiV Healthcare, jointly owned by GSK, Pfizer and Shionogi together with the UN’s Medicine Patent Pool (MPP) on Thursday issued sub-licenses to Aurobindo, Cipla and Viatris to manufacture generic versions of HIV preventive therapy cabotegravir long-acting injection for (pre-exposure prophylaxis (PrEP) for 90 low and middle income countries (LMICs) including India. The licences will enable ...
Ingredion Acquisitions: Ingredion open for acquisitions, partnerships in India to expand business
Ingredion, the US-based maker of pharmaceutical excipients and food ingredients, is eyeing acquisitions and partnerships to crack the Indian market and also use it as a base for exports. In an interview to ET, Jim Zallie, president and CEO of Ingredion, said he is betting big on India, given its rising economy, industry friendly policies ...
Indian Drug Companies: Indian govt to take action against 76 drug companies for shoddy products
Indian drug authorities have taken action against 76 drug companies this month for selling adulterated or fake products in one of the largest crackdowns on the industry in the country, a government source told Reuters on Thursday. Health Minister Mansukh Mandaviya confirmed a crackdown but did not give details of companies against which action had ...
Granules packaging facility: Indian pharma firm Granules opens packaging facility in US’ Virginia
Indian pharmaceutical company Granules has opened a packaging facility in the Virginia State of the US to expand the packaging capacity of essential drugs in the state, thus strengthening the biopharma supply chain. The facility was inaugurated by India‘s Ambassador to the US Taranjit Singh Sandhu. Granules, which was one of the first Indian pharmaceutical ...
usfda: Granules India receives USFDA approval for generic gabapentin tablets
Pharmaceuticals firm Granules India Ltd on Wednesday said it has received approval from the US health regulator for its generic gabapentin tablets indicated for management of postherpetic neuralgia in adults. The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Gabapentin tablets of strengths 600 mg ...
Viatris puts India API business on the block
Mumbai: US healthcare company Viatris Inc has put up its India-focussed active pharmaceutical ingredients (API) business for sale as part of reorganising its non-core portfolio. This follows the decision to also sell women’s healthcare business Famy Care last year, said people aware of the development. However, the API sale process, which was launched a couple ...
500 LPM capacity Oxygen plant set up at the GMCH Guwahati’s Cardiothoracic & Neuroscience Centre
An Oxygen plant with 500 LPM capacity, set up at the Cardiothoracic & Neuroscience Centre, GMCH Guwahati. It was dedicated to the people of Assam by the state’s Health and Family Welfare Minister, Keshab Mahanta. Bayer has set up the oxygen plant at the CN Centre of the Gauhati Medical College and Hospital (GMCH), in ...
JB Pharma bets big on chronic therapy for its growth aspirations
Mumbai: JB Chemicals & Pharmaceuticals (JB Pharma) is eyeing possible acquisitions of brands and portfolios to get a foothold in the diabetes segment, its CEO Nikhil Chopra has said. “We would like to explore things inorganically in the world of metabolics,” Chopra told ET in an interview. He didn’t provide further details like whether the ...